IKBKB and breast carcinoma: The evidence for osteoblast-specific IKKβ in these processes comes from the experiments that demonstrated that pre-exposure of osteoblasts to IKKβ inhibitors tested significantly reduced breast cancer-induced osteoclast formation in osteoblast–osteoclast co-cultures.